US Bancorp DE Decreases Stake in UnitedHealth Group Incorporated $UNH

US Bancorp DE decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,040,644 shares of the healthcare conglomerate's stock after selling 54,113 shares during the period. US Bancorp DE owned 0.11% of UnitedHealth Group worth $324,654,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Values Added Financial LLC grew its position in shares of UnitedHealth Group by 24.3% during the 2nd quarter. Values Added Financial LLC now owns 1,105 shares of the healthcare conglomerate's stock valued at $345,000 after acquiring an additional 216 shares during the period. Notis McConarty Edward grew its position in shares of UnitedHealth Group by 11.9% during the 2nd quarter. Notis McConarty Edward now owns 8,837 shares of the healthcare conglomerate's stock valued at $2,757,000 after acquiring an additional 941 shares during the period. Trifecta Capital Advisors LLC boosted its holdings in UnitedHealth Group by 4.9% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 10,360 shares of the healthcare conglomerate's stock worth $3,232,000 after buying an additional 481 shares during the period. Windle Wealth LLC bought a new position in UnitedHealth Group in the 2nd quarter worth approximately $220,000. Finally, Morey & Quinn Wealth Partners LLC boosted its holdings in UnitedHealth Group by 4.5% in the 2nd quarter. Morey & Quinn Wealth Partners LLC now owns 1,778 shares of the healthcare conglomerate's stock worth $555,000 after buying an additional 77 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $369.88 on Thursday. The firm's 50-day moving average price is $313.51 and its two-hundred day moving average price is $352.54. The stock has a market capitalization of $334.99 billion, a price-to-earnings ratio of 16.03, a PEG ratio of 2.35 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group's payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Bank of America raised their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a "neutral" rating in a report on Wednesday. Sanford C. Bernstein raised their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an "outperform" rating in a report on Wednesday. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $372.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.